世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

米国の外科手術市場:タイプ別(消化器、心臓血管、歯科、美容、泌尿器、眼科、整形外科、耳鼻科、婦人科手術)、チャネル別(医師オフィス、病院、(入院、外来)、ASC)-2027年までの予測


US Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Gynecologic Surgical Procedures), Channel (Physician Offices, Hospitals, (Inpatient, Outpatient), ASC) - Forecast to 2027

米国の外科手術市場は、2022年の105,814.5千件から2027年には122,881.5千件に達し、予測期間中のCAGRは3.0%と予測されます。この市場の成長は、主にがんの有病率の増加、慢性疾患の増加、医療施設への投資の増加... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ
2022年5月2日 US$4,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
78 45 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

米国の外科手術市場は、2022年の105,814.5千件から2027年には122,881.5千件に達し、予測期間中のCAGRは3.0%と予測されます。この市場の成長は、主にがんの有病率の増加、慢性疾患の増加、医療施設への投資の増加、外科手術の技術的進歩、老年人口の増加などに起因しています。外科手術、麻酔、集中治療技術の進歩により、拡大する高齢者人口のうち外科手術を受ける人の割合が多くなっており、これが米国の外科手術市場の成長を牽引することになります。
本レポートでは、米国の外科手術市場をタイプおよびチャネルに基づいて区分しています。タイプに基づいて、米国の外科手術市場は、消化器外科手術、心臓血管外科手術、歯科外科手術、美容外科手術、泌尿器科外科手術、眼科外科手術、整形外科手術、耳鼻科外科手術、産科/婦人科外科手術、およびその他の外科手術に区分される。
2021年には、歯科用外科処置のセグメントがこの市場の最大のシェアを占めました。このセグメントのシェアは、口腔ケアに対する意識の高まり、口腔疾患の有病率の増加、高齢化率の上昇とそれに伴う歯の喪失に起因するものと考えられる。眼科外科処置セグメントは、予測期間中に最も高いCAGRで成長すると推定されます。この分野の高い成長は、緑内障、白内障、糖尿病性網膜症などのさまざまな眼科疾患の有病率が老年人口で上昇し、それに伴って眼病が増加していることに起因していると思われます。
米国の外科手術市場は、チャネルに基づいて、医師オフィス、病院、外来手術センターに区分されます。2021年には、医師オフィスセグメントがこの市場の最大のシェアを占めました。このセグメントの最大シェアは、歯科処置、上部内視鏡検査、結腸鏡検査、鼻形成術、乳房形成術、結石除去術、または血管アクセス関連処置などの低侵襲手術の増加および医師オフィスで行われる手術の多さに起因するものと考えられます。外来手術センターセグメントは、予測期間中に最も高いCAGRで成長すると推定されます。このセグメントのCAGRが最も高いのは、コスト削減の可能性と、患者の間でより良い、より迅速なケアへの需要が高まっていることに起因すると考えられる。
調査対象
このレポートは米国の外科手術市場を分析し、タイプやチャネルなどの様々なセグメントに基づいて、外科手術のボリュームとこの市場の将来の成長可能性を推定することを目的としています。
レポートを購入する理由
レポートでは、確立された企業だけでなく、新規参入者/小規模な企業は、順番に、市場のより重要なシェアを獲得するのに役立つだろう、市場のパルスを測定するために豊かになります。本レポートを購入された企業は、下記の戦略のいずれか、または組み合わせて使用することで、市場での地位を強化することができます。
本レポートでは、以下のポイントについて考察しています。
- 新興技術分析。外科的処置における有利な新興技術の進歩に関する包括的な情報
- 定量的な分析。米国で実行される手術のさまざまな種類の数についての包括的な情報。

ページTOPに戻る


目次

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 11
1.3 SCOPE OF THE STUDY 12
1.3.1 MARKETS COVERED 12
FIGURE 1 US OUTPATIENT SURGICAL PROCEDURES MARKET 12
1.3.2 YEARS CONSIDERED FOR THE STUDY 12
1.4 STAKEHOLDERS 13
1.5 SUMMARY OF CHANGES 13
1.6 LIMITATIONS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 14
FIGURE 2 RESEARCH DESIGN 14
2.1.1 SECONDARY DATA 14
2.1.1.1 Key data from secondary sources 15
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 16
2.1.2.2 Key industry insights 17
2.2 MARKET ESTIMATION 17
FIGURE 3 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE US SURGICAL PROCEDURES MARKET (2022–2027) 18
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 19
FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 19
2.4 ASSUMPTIONS FOR THE STUDY 20
2.5 METHODOLOGY-RELATED LIMITATIONS 20
3 EXECUTIVE SUMMARY 21
FIGURE 5 US SURGICAL PROCEDURES MARKET, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 21
FIGURE 6 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 22
FIGURE 7 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 22
FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 23
FIGURE 9 COSMETIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 23
FIGURE 10 UROLOGIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 24
FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 24
FIGURE 12 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 25
FIGURE 13 ENT SURGICAL PROCEDURES MARKET, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 25
FIGURE 14 OBSTETRIC/ GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 26
FIGURE 15 US SURGICAL PROCEDURES MARKET, BY CHANNEL,
2022 VS. 2027 (THOUSAND PROCEDURES) 26
4 PREMIUM INSIGHTS 28
4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 28
FIGURE 16 GROWTH IN GERIATRIC POPULATION AND RISE IN CHRONIC DISEASES TO DRIVE MARKET GROWTH 28
4.2 US SURGICAL PROCEDURES MARKET, BY TYPE 29
FIGURE 17 DENTAL SURGICAL PROCEDURES SEGMENT TO HOLD THE LARGEST SHARE OF THE US SURGICAL PROCEDURES MARKET IN 2021 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
FIGURE 18 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
5.2.1 DRIVERS 31
5.2.1.1 Growing prevalence of cancer requiring surgical treatment 31
FIGURE 19 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 31
FIGURE 20 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 32
5.2.1.2 Growth in geriatric population and rise in chronic diseases 32
FIGURE 21 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 33
5.2.1.3 Technological advancements in surgical procedures 34
TABLE 1 US: RISE IN SURGICAL PROCEDURES 34
FIGURE 22 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 35
5.2.2 RESTRAINTS 35
5.2.2.1 Shortage of surgeons 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Increasing adoption of outpatient surgeries 36
5.2.4 CHALLENGES 36
5.2.4.1 Surgical errors 36
5.2.4.2 Complications associated with surgical procedures 38
TABLE 2 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 38

6 INDUSTRY INSIGHTS 40
6.1 INTRODUCTION 40
6.2 INDUSTRY TRENDS 40
6.2.1 MINIMALLY INVASIVE SURGERY 40
6.2.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 41
6.3 REIMBURSEMENT SCENARIO 42
TABLE 3 LIST OF SURGICAL PROCEDURE CODES 43
6.4 IMPACT OF COVID-19 ON THE US SURGICAL PROCEDURES MARKET 44
6.5 TECHNOLOGY ANALYSIS 45
7 US SURGICAL PROCEDURES MARKET, BY TYPE 46
7.1 INTRODUCTION 47
TABLE 4 US: SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2027 (THOUSAND) 47
7.2 DENTAL SURGICAL PROCEDURES 48
7.2.1 INCREASING PREVALENCE OF ORAL DISEASES AND RISING AWARENESS OF DENTAL CARE DRIVE THE GROWTH OF DENTAL SURGICAL PROCEDURES 48
TABLE 5 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 48
7.3 ORTHOPEDIC SURGICAL PROCEDURES 49
7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED ORTHOPEDIC DEVICES WILL INCREASE THE NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES 49
TABLE 6 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 50
7.4 GASTROINTESTINAL SURGICAL PROCEDURES 50
7.4.1 THE INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES IS DRIVING GROWTH IN THIS SEGMENT 50
FIGURE 23 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 51
TABLE 7 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 52
7.5 OPHTHALMIC SURGICAL PROCEDURES 52
7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY DRIVE DEMAND FOR OPHTHALMIC SURGICAL TREATMENT IN THE US 52
TABLE 8 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 53
7.6 CARDIOVASCULAR SURGICAL PROCEDURES 53
7.6.1 HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE US 53
TABLE 9 US: NUMBER OF CASES OF CARDIOVASCULAR DISEASES,
2015-2035 (MILLION) 54
FIGURE 24 US: MORTALITY RATE OF CARDIOVASCULAR DISEASES, BY TYPE, 2018 55
TABLE 10 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 55
7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 56
7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES DRIVES MARKET GROWTH 56
TABLE 11 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 57
7.8 ENT SURGICAL PROCEDURES 57
7.8.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY ARE MAJOR REASONS FOR THE GROWTH OF ENT SURGICAL PROCEDURES 57
TABLE 12 US: ENT SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 58
7.9 COSMETIC SURGICAL PROCEDURES 58
7.9.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES BOOSTS
THE ADOPTION OF COSMETIC SURGERIES 58
TABLE 13 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 60
7.10 UROLOGIC SURGICAL PROCEDURES 60
7.10.1 INCREASING INCIDENCE OF DIABETES AND HIGH BLOOD PRESSURE INCREASES THE RISK OF KIDNEY DISEASES 60
TABLE 14 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 61
7.11 OTHER SURGICAL PROCEDURES 61
TABLE 15 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 62
TABLE 16 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 62
TABLE 17 US: INTEGUMENTARY SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 63
8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 64
8.1 INTRODUCTION 65
TABLE 18 US SURGICAL PROCEDURES MARKET, BY CHANNEL,
2020–2027 (THOUSAND) 65
8.2 PHYSICIAN OFFICES 65
8.2.1 TECHNOLOGICAL ADVANCES MAKING OFFICE-BASED SURGERY MORE FEASIBLE DRIVE THE MARKET GROWTH 65
8.3 HOSPITALS 66
TABLE 19 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 66
TABLE 20 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE,
2020–2027 (THOUSAND) 67
8.3.1 INPATIENT SURGERIES 67
8.3.1.1 Increasing incidences of cardiovascular, neurological, and intestinal disorders are driving growth for this market 67
FIGURE 25 US NATIONAL INPATIENT STAYS, 2016–2018 68
8.3.2 OUTPATIENT SURGERIES 68
8.3.2.1 Convenience and lower cost are major advantages of outpatient surgeries 68
8.4 AMBULATORY SURGERY CENTERS 69
8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS PROPEL THE GROWTH OF
THIS SEGMENT 69

9 APPENDIX 71
9.1 DISCUSSION GUIDE 71
9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 76
9.3 RELATED REPORTS 78
9.4 AUTHOR DETAILS 79

 

ページTOPに戻る


 

Summary

The US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period. The growth of this market is mainly attributed to the growing prevalence of cancer, rise in chronic diseases, increased investment in health facilities, technological advancements in surgical procedures and growth in geriatric population. Advances in surgical, anesthetic, and intensive care techniques have led a larger proportion of expanding elderly population to undergo surgical procedures, which will drive the growth of the US surgical procedures market.
In this report, the US surgical procedures market is segmented based on type and channel. Based on type, the US surgical procedures market is segmented into gastrointestinal surgical procedures, cardiovascular surgical procedures, dental surgical procedures, cosmetic surgical procedures, urologic surgical procedures, ophthalmic surgical procedures, orthopedic surgical procedures, ENT surgical procedures, obstetric/gynecologic surgical procedures, and other surgical procedures.
In 2021, the dental surgical procedures segment accounted for the largest share of this market. The share of this segment can be attributed to the increasing awareness of oral care, increasing prevalence of oral diseases, and rising aging population and the associated teeth loss. The ophthalmic surgical procedures segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the prevalence of various ophthalmic disorders such as glaucoma, cataract, and diabetic retinopathy rise in the geriatric population and the associated increase in eye diseases.
Based on channel, the US surgical procedures market is segmented into physician offices, hospitals, and ambulatory surgery centers. In 2021, the physician offices segment accounted for the largest share of this market. The largest share of this segment can be attributed to the increasing number of minimally invasive surgeries and high number of surgeries performed in physician offices such as dental procedures, upper endoscopy, colonoscopy, rhinoplasty, mammoplasty, lithotripsy, or vascular access-related procedures. The ambulatory surgery center segment is estimated to grow at the highest CAGR during the forecast period. The highest CAGR of this segment can be attributed to the potential for cost reductions and the rising demand for better and quicker care among patients.
Research Coverage:
The report analyzes the US surgical procedures market and aims at estimating the surgical procedures volume and future growth potential of this market based on various segments such as type and channel.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Emerging Technology Analysis: Comprehensive information on the lucrative emerging technological advancements in surgical procedures
• Quantitative Analysis: Exhaustive information about number of various types of surgeries performed in the US.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 11
1.3 SCOPE OF THE STUDY 12
1.3.1 MARKETS COVERED 12
FIGURE 1 US OUTPATIENT SURGICAL PROCEDURES MARKET 12
1.3.2 YEARS CONSIDERED FOR THE STUDY 12
1.4 STAKEHOLDERS 13
1.5 SUMMARY OF CHANGES 13
1.6 LIMITATIONS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 14
FIGURE 2 RESEARCH DESIGN 14
2.1.1 SECONDARY DATA 14
2.1.1.1 Key data from secondary sources 15
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 16
2.1.2.2 Key industry insights 17
2.2 MARKET ESTIMATION 17
FIGURE 3 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE US SURGICAL PROCEDURES MARKET (2022–2027) 18
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 19
FIGURE 4 MARKET DATA TRIANGULATION METHODOLOGY 19
2.4 ASSUMPTIONS FOR THE STUDY 20
2.5 METHODOLOGY-RELATED LIMITATIONS 20
3 EXECUTIVE SUMMARY 21
FIGURE 5 US SURGICAL PROCEDURES MARKET, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 21
FIGURE 6 GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 22
FIGURE 7 CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 22
FIGURE 8 DENTAL SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 23
FIGURE 9 COSMETIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 23
FIGURE 10 UROLOGIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 24
FIGURE 11 OPHTHALMIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 24
FIGURE 12 ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 25
FIGURE 13 ENT SURGICAL PROCEDURES MARKET, BY TYPE,
2022 VS. 2027 (THOUSAND PROCEDURES) 25
FIGURE 14 OBSTETRIC/ GYNECOLOGIC SURGICAL PROCEDURES MARKET, BY TYPE, 2022 VS. 2027 (THOUSAND PROCEDURES) 26
FIGURE 15 US SURGICAL PROCEDURES MARKET, BY CHANNEL,
2022 VS. 2027 (THOUSAND PROCEDURES) 26
4 PREMIUM INSIGHTS 28
4.1 US SURGICAL PROCEDURES MARKET OVERVIEW 28
FIGURE 16 GROWTH IN GERIATRIC POPULATION AND RISE IN CHRONIC DISEASES TO DRIVE MARKET GROWTH 28
4.2 US SURGICAL PROCEDURES MARKET, BY TYPE 29
FIGURE 17 DENTAL SURGICAL PROCEDURES SEGMENT TO HOLD THE LARGEST SHARE OF THE US SURGICAL PROCEDURES MARKET IN 2021 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
FIGURE 18 US SURGICAL PROCEDURES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
5.2.1 DRIVERS 31
5.2.1.1 Growing prevalence of cancer requiring surgical treatment 31
FIGURE 19 US: CANCER CASES, BY TYPE, 2020–2040 (THOUSANDS) 31
FIGURE 20 US: NEW CANCER CASES, 2012–2022 (MILLION INDIVIDUALS) 32
5.2.1.2 Growth in geriatric population and rise in chronic diseases 32
FIGURE 21 US: NUMBER OF PEOPLE WITH CHRONIC CONDITIONS, 1995–2030 (MILLION) 33
5.2.1.3 Technological advancements in surgical procedures 34
TABLE 1 US: RISE IN SURGICAL PROCEDURES 34
FIGURE 22 US: R&D INVESTMENTS IN MEDICAL TECHNOLOGY, 2013-2018 (MILLION) 35
5.2.2 RESTRAINTS 35
5.2.2.1 Shortage of surgeons 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Increasing adoption of outpatient surgeries 36
5.2.4 CHALLENGES 36
5.2.4.1 Surgical errors 36
5.2.4.2 Complications associated with surgical procedures 38
TABLE 2 COMPLICATIONS ASSOCIATED WITH SURGICAL PROCEDURES 38

6 INDUSTRY INSIGHTS 40
6.1 INTRODUCTION 40
6.2 INDUSTRY TRENDS 40
6.2.1 MINIMALLY INVASIVE SURGERY 40
6.2.2 INCREASING ADOPTION OF ADVANCED ROBOTICS IN ASCS 41
6.3 REIMBURSEMENT SCENARIO 42
TABLE 3 LIST OF SURGICAL PROCEDURE CODES 43
6.4 IMPACT OF COVID-19 ON THE US SURGICAL PROCEDURES MARKET 44
6.5 TECHNOLOGY ANALYSIS 45
7 US SURGICAL PROCEDURES MARKET, BY TYPE 46
7.1 INTRODUCTION 47
TABLE 4 US: SURGICAL PROCEDURES MARKET, BY TYPE, 2020–2027 (THOUSAND) 47
7.2 DENTAL SURGICAL PROCEDURES 48
7.2.1 INCREASING PREVALENCE OF ORAL DISEASES AND RISING AWARENESS OF DENTAL CARE DRIVE THE GROWTH OF DENTAL SURGICAL PROCEDURES 48
TABLE 5 US: DENTAL SURGICAL PROCEDURES, BY TYPE, 2020-2027 (THOUSAND) 48
7.3 ORTHOPEDIC SURGICAL PROCEDURES 49
7.3.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED ORTHOPEDIC DEVICES WILL INCREASE THE NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES 49
TABLE 6 US: ORTHOPEDIC SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 50
7.4 GASTROINTESTINAL SURGICAL PROCEDURES 50
7.4.1 THE INCREASING NUMBER OF GASTROINTESTINAL CANCER CASES IS DRIVING GROWTH IN THIS SEGMENT 50
FIGURE 23 US: STOMACH CANCER INCIDENCE, 2020–2040 (THOUSANDS) 51
TABLE 7 US: GASTROINTESTINAL SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 52
7.5 OPHTHALMIC SURGICAL PROCEDURES 52
7.5.1 RISING PREVALENCE OF GLAUCOMA, CATARACT, AND DIABETIC RETINOPATHY DRIVE DEMAND FOR OPHTHALMIC SURGICAL TREATMENT IN THE US 52
TABLE 8 US: OPHTHALMIC SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 53
7.6 CARDIOVASCULAR SURGICAL PROCEDURES 53
7.6.1 HEART DISEASE IS THE LEADING CAUSE OF DEATH IN THE US 53
TABLE 9 US: NUMBER OF CASES OF CARDIOVASCULAR DISEASES,
2015-2035 (MILLION) 54
FIGURE 24 US: MORTALITY RATE OF CARDIOVASCULAR DISEASES, BY TYPE, 2018 55
TABLE 10 US: CARDIOVASCULAR SURGICAL PROCEDURES, BY TYPE,
2020-2027 (THOUSAND) 55
7.7 OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES 56
7.7.1 INCREASING INCIDENCE OF GYNECOLOGICAL DISEASES DRIVES MARKET GROWTH 56
TABLE 11 US: OBSTETRIC/GYNECOLOGIC SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 57
7.8 ENT SURGICAL PROCEDURES 57
7.8.1 RISING DISPOSABLE INCOME AND INCREASING AFFORDABILITY ARE MAJOR REASONS FOR THE GROWTH OF ENT SURGICAL PROCEDURES 57
TABLE 12 US: ENT SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 58
7.9 COSMETIC SURGICAL PROCEDURES 58
7.9.1 ADVENT OF MINIMALLY INVASIVE SURGICAL PROCEDURES BOOSTS
THE ADOPTION OF COSMETIC SURGERIES 58
TABLE 13 US: COSMETIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 60
7.10 UROLOGIC SURGICAL PROCEDURES 60
7.10.1 INCREASING INCIDENCE OF DIABETES AND HIGH BLOOD PRESSURE INCREASES THE RISK OF KIDNEY DISEASES 60
TABLE 14 US: UROLOGIC SURGICAL PROCEDURES, BY TYPE, 2020–2027 (THOUSAND) 61
7.11 OTHER SURGICAL PROCEDURES 61
TABLE 15 US: NERVOUS SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 62
TABLE 16 US: ENDOCRINE SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 62
TABLE 17 US: INTEGUMENTARY SYSTEM SURGICAL PROCEDURES, BY TYPE,
2020–2027 (THOUSAND) 63
8 US SURGICAL PROCEDURES MARKET, BY CHANNEL 64
8.1 INTRODUCTION 65
TABLE 18 US SURGICAL PROCEDURES MARKET, BY CHANNEL,
2020–2027 (THOUSAND) 65
8.2 PHYSICIAN OFFICES 65
8.2.1 TECHNOLOGICAL ADVANCES MAKING OFFICE-BASED SURGERY MORE FEASIBLE DRIVE THE MARKET GROWTH 65
8.3 HOSPITALS 66
TABLE 19 US: NUMBER OF REGISTERED HOSPITALS, BY NUMBER OF BEDS (2019) 66
TABLE 20 US SURGICAL PROCEDURES MARKET FOR HOSPITALS, BY TYPE,
2020–2027 (THOUSAND) 67
8.3.1 INPATIENT SURGERIES 67
8.3.1.1 Increasing incidences of cardiovascular, neurological, and intestinal disorders are driving growth for this market 67
FIGURE 25 US NATIONAL INPATIENT STAYS, 2016–2018 68
8.3.2 OUTPATIENT SURGERIES 68
8.3.2.1 Convenience and lower cost are major advantages of outpatient surgeries 68
8.4 AMBULATORY SURGERY CENTERS 69
8.4.1 LOWER COSTS AND SHORTER PATIENT STAYS PROPEL THE GROWTH OF
THIS SEGMENT 69

9 APPENDIX 71
9.1 DISCUSSION GUIDE 71
9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 76
9.3 RELATED REPORTS 78
9.4 AUTHOR DETAILS 79

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(通信回線)の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD(cardiovascular)の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04 10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る